Vecabrutinib

Overview

Vecabrutinib (SNS-062) is a potent, noncovalent BTK and ITK inhibitor, with K d values of 0.3 nM and 2.2 nM, respectively. Vecabrutinib shows an IC 50 of 24 nM for ITK .

Application

Products | Products > Disease Areas > Coronavirus Infection | Products > Disease Areas > Autoimmune Disease | Products > Disease Areas > Arthritis | Products > Disease Areas > Leukemia/Lymphoma/Myeloma | Products > Disease Areas > Blood Disease | Products > Disease Areas > SARS-CoV-2 Infection | Products > Disease Areas > Rheumatoid Arthritis | Products > Disease Areas > Cancer | Products > Disease Areas > Infection | Products > Disease Areas > Inflammation or Immune System Disease | Products > Disease Areas > Blood or Cardio-cerebrovascular Disease | Products > Disease Areas > Musculoskeletal and Skin Disease | Products > Signaling Pathways > Protein Tyrosine Kinase/RTK | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Signaling Pathways > Btk | Products > Signaling Pathways > Itk

Product Information

• Catalog No.: HY-109078
• CAS No.: 1510829-06-7
• Molecular Formula: C22H24ClF4N7O2
• Molecular Weight: 529.92
• Purity: 99.76%
• Storage: Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 2 years , -20°C, 1 year
• Solubility: ≥ 2.5 mg/mL (4.72 mM); Clear solution
• Availability: In-stock

Source

Original product source